Gaucher disease trials in India
1 of 2 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in IndiaStudy to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)
- Where
- Jaipur, New Delhi
- Age
- 4 years to 30 years
- People
- 20 worldwide
- Run by
- Azafaros B.V.
See details and how to joinNCT07715084